Search

everythinglearnresearchcommunity

for

Search:↓

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Mutations in certain receptors can cause diseases and offer new treatment options.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

DHT stops hair regrowth in mice, similar to human hair loss.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

We need better ways to test and understand SARMs to make safer and more effective treatments.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.